jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Alanine Transaminase (SGPT)

Liver
image

Report in 4Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Alanine transaminase enzyme; elevated in liver cell damage from hepatitis, alcohol, or fatty liver.

49190

74% OFF

Alanine Transaminase (SGPT) - Comprehensive Medical Test Information Guide

  • Why is it done?
    • Test measures the level of alanine transaminase (ALT), an enzyme primarily found in liver cells and, to a lesser extent, in muscle tissue, heart, and kidney cells
    • Detects liver damage and disease by measuring enzyme elevation released when liver cells are damaged or inflamed
    • Ordered to diagnose or monitor liver conditions such as hepatitis, cirrhosis, and fatty liver disease
    • Evaluates effectiveness of treatments for liver disease and alcohol-related liver damage
    • Monitors side effects of medications known to affect liver function
    • Assesses liver health as part of routine physical examinations or health screenings
    • Typically performed during annual check-ups, when patients present with symptoms of liver disease, or when monitoring chronic conditions
  • Normal Range
    • Normal reference range typically: 7-56 IU/L (International Units per Liter)
    • Range may vary slightly between laboratories, with some reporting 4-36 IU/L or 10-40 IU/L
    • Values may be slightly higher in men than women; reference ranges may differ based on age
    • Normal (Negative): ALT levels within the normal range indicate no significant liver damage or disease
    • Elevated (Positive): ALT levels above the normal range suggest liver damage, inflammation, or disease requiring further investigation
    • Moderately elevated (2-5 times normal): Suggests mild to moderate liver injury from viral hepatitis, alcohol, or medications
    • Markedly elevated (>5 times normal): Indicates significant liver damage from acute hepatitis, cirrhosis, or acute liver failure
  • Interpretation
    • Mild elevation (50-100 IU/L): May indicate fatty liver disease, muscle injury, recent heavy exercise, or early-stage liver inflammation
    • Moderate elevation (100-400 IU/L): Suggests acute hepatitis, medication-induced liver injury, or active cirrhosis
    • Marked elevation (>1000 IU/L): Indicates acute viral hepatitis, autoimmune hepatitis, or acute acetaminophen toxicity
    • ALT/AST ratio significance: ALT-predominant elevation (ALT > AST) suggests viral hepatitis or non-alcoholic fatty liver disease; AST-predominant elevation suggests alcoholic liver disease or cirrhosis
    • Factors affecting results:
    • Medications (statins, antibiotics, anti-tuberculosis drugs, acetaminophen)
    • Intense physical exercise or muscle injury
    • Hemolysis or lipemia in blood sample
    • Obesity and insulin resistance
    • Pregnancy may cause slight elevation
    • Clinical significance: ALT is more liver-specific than AST; it is considered a sensitive marker for detecting hepatocellular injury even in early stages
  • Associated Organs
    • Primary organ: Liver (primary source of ALT enzyme)
    • Secondary organs affected: Skeletal muscle, heart, kidneys, pancreas (ALT found in smaller amounts)
    • Conditions commonly associated with elevated ALT:
    • Viral hepatitis (A, B, C, E)
    • Autoimmune hepatitis
    • Non-alcoholic fatty liver disease (NAFLD)
    • Alcoholic liver disease
    • Cirrhosis
    • Drug-induced liver injury (acetaminophen, statins, antituberculosis agents)
    • Liver cancer (hepatocellular carcinoma)
    • Hemochromatosis (iron overload)
    • Wilson's disease (copper accumulation)
    • Rhabdomyolysis (muscle breakdown)
    • Myocardial infarction (heart attack)
    • Pancreatitis (pancreatic inflammation)
    • Potential complications of abnormal results:
    • Progressive liver fibrosis and cirrhosis if underlying cause is not treated
    • Liver failure and need for transplantation
    • Portal hypertension with bleeding esophageal varices
    • Hepatic encephalopathy (brain dysfunction from toxin accumulation)
    • Development of liver cancer in cirrhotic livers
  • Follow-up Tests
    • Recommended additional tests if ALT is elevated:
    • Aspartate Aminotransferase (AST) - to compare liver enzyme patterns
    • Alkaline Phosphatase (ALP) - to assess biliary function
    • Total and direct bilirubin - to assess liver synthetic function
    • Gamma-glutamyl transferase (GGT) - to differentiate liver vs. bone source of elevated ALP
    • Albumin and prothrombin time (PT/INR) - to assess synthetic function
    • Hepatitis A, B, C serology - to screen for viral hepatitis
    • Autoimmune antibodies (ANA, anti-smooth muscle) - to screen for autoimmune hepatitis
    • Lipid panel - to evaluate for metabolic syndrome and fatty liver
    • Abdominal ultrasound - to visualize liver structure and exclude focal lesions
    • CT or MRI of abdomen - for detailed liver imaging if cirrhosis or cancer suspected
    • FibroTest or FIB-4 score - to assess degree of liver fibrosis non-invasively
    • Liver biopsy - definitive test if other investigations inconclusive
    • Transient elastography (FibroScan) - to measure liver stiffness indicating fibrosis
    • Monitoring frequency:
    • For chronic hepatitis: Every 3-6 months to monitor disease progression and treatment response
    • For patients on hepatotoxic medications: Every 3-6 months or as recommended by prescribing physician
    • For cirrhosis: Every 3 months for surveillance of complications and HCC screening
    • Healthy individuals: Annually as part of routine screening
  • Fasting Required?
    • Fasting requirement: No - Fasting is NOT required for ALT testing
    • However, fasting may be recommended if additional tests like lipid panel or glucose are being performed simultaneously
    • Medications: No need to discontinue medications unless specifically instructed by physician
    • Inform healthcare provider of all medications, supplements, and herbal products being taken, as some may affect liver function
    • Patient preparation requirements:
    • Normal diet and fluid intake can be maintained
    • Avoid intense physical exercise 24 hours before the test, as this can elevate ALT levels
    • Avoid heavy alcohol consumption for 24-48 hours before testing
    • Bring valid identification and insurance information to the testing facility
    • Blood draw can be performed in any venipuncture setting (laboratory, hospital, clinic)
    • No special collection containers needed - standard venipuncture tube for serum

How our test process works!

customers
customers